XML 21 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows
$ in Thousands
12 Months Ended
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Statement of Cash Flows [Abstract]      
Net income (loss) $ 85,097 $ (25,015) $ (9,484)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Premium amortization and (discount accretion) on investments, net (2,070) (548) 5,086
Interest income earned added to principal of securities (46) (413) (207)
Amortization of deferred financing costs 192 191 486
Amortization of discount on convertible senior unsecured notes 137 0 0
Restricted stock amortization 981 1,699 2,301
Premium amortization for MAC interest rate swaps 0 (658) (1,250)
Interest payments and basis recovered on MAC interest rate swaps 525 658 1,595
Premium on purchase of Residential Whole-Loans (1,239) (574) (3,329)
Premium on purchase of Residential Bridge Loans (753) 0 0
Unrealized (gain) loss, net (28,396) 17,107 34,011
Unrealized loss on derivative instruments, net (148,308) 5,135 73,599
Other than temporary impairment 22,873 32,286 19,791
Realized (gain) loss on sale of investments, net (20,598) 21,991 (8,279)
(Gain) loss on derivatives, net 156,076 (41,516) 13,920
Loss (gain) on foreign currency transactions, net 1 758 (2,130)
Changes in operating assets and liabilities:      
Decrease (increase) in accrued interest receivable 5,209 3,809 4,688
Decrease (increase) in other assets (1,763) (16) (56)
Increase (decrease) in accrued interest payable (7,719) (4,390) 2,858
Increase (decrease) in accounts payable and accrued expenses (274) 1,477 (16)
Increase (decrease) in payable to related party (543) (435) 314
Net cash provided by operating activities 59,382 11,546 133,898
Cash flows from investing activities:      
Purchase of securities (2,881,276) (2,172,623) (1,354,274)
Proceeds from sale of securities 1,593,914 2,273,922 2,547,364
Principal repayments and basis recovered on securities 240,785 344,937 397,073
Purchase of Residential Whole-Loans (87,640) (28,825) (225,870)
Principal repayments on Residential Whole-Loans 42,176 52,473 20,355
Purchase of Commercial Whole-Loans 0 0 (8,750)
Principal repayments on Commercial Whole-Loans 0 0 8,750
Purchase of securitized commercial loan 0 0 (14,000)
Principal repayments on securitized commercial loan 154 0 0
Purchase of Residential Bridge Loans (142,913) 0 0
Purchase of Residential Bridge Loans 31,794 0 0
Payment of premium for option derivatives (16,355) (17,951) (16,064)
Premium received from option derivatives 14,553 22,707 15,354
Premium received from credit default swap 74 0 0
Net settlements of TBAs 4,035 6,140 3,710
Proceeds from (Payments on) termination of futures, net (9,130) 23,609 (527)
Proceeds from sale of interest rate swaptions 0 2,075 32,186
Premium for MAC interest rate swaps, net 0 465 (3,858)
Payments on termination of MAC interest rate swaps 0 0 (186)
Due from counterparties 8,449 (8,449) 0
Proceeds from termination of foreign currency swaps 0 6,771 0
Payments on total return swaps (552) 38 0
Interest payments and basis recovered on MAC interest rate swaps (525) (658) (1,193)
Premium for interest rate swaptions, net (115) 0 (40,215)
Net cash provided by (used in) investing activities (1,202,572) 504,631 1,359,855
Cash flows from financing activities:      
Payment of offering costs (94) 0 0
Repurchase of common stock (1,094) 0 0
Proceeds from repurchase agreement borrowings 18,438,166 15,977,505 17,544,060
Proceeds from convertible note offering 115,000 0 0
Repayments of repurchase agreement borrowings (17,342,124) (16,407,929) (18,863,913)
Proceeds from (Repayment of) cash overdraft 0 (300) 300
Repayments of securitized debt (68) 0 0
Proceeds from forward contracts 8,246 112,574 242,279
Repayments of forward contracts (8,214) (112,640) (243,180)
Payments on termination of MAC interest rate swaps containing an other-than-insignificant financing element 0 0 (18,655)
Interest payments and basis recovered on MAC interest rate swaps containing an other-than-insignificant financing element 0 0 (402)
Payments made for deferred financing costs (3,837) (58) (620)
Due from counterparties, net (9,707) 14,427 (64,806)
Due to counterparties, net 750 (9,210) (2,230)
Dividends paid on common stock (51,981) (69,168) (109,272)
Net cash provided by (used in) financing activities 1,145,043 (494,799) (1,516,439)
Effect of exchange rate changes on cash and cash equivalents (1) 83 175
Net increase (decrease) in cash and cash equivalents 1,852 21,461 (22,511)
Cash and cash equivalents beginning of period 46,172 24,711 47,222
Cash and cash equivalents end of period 48,024 46,172 24,711
Supplemental disclosure of operating cash flow information:      
Interest paid 43,032 32,041 27,515
Income taxes paid 4,966 2,093 0
Supplemental disclosure of non-cash financing/investing activities:      
Repurchase of common stock, not settled (137) 0 0
Principal payments of securities, not settled 0 0 572
Securities purchased, not settled (17,217) (309,086) (66,146)
Assets of CSMC Trust 0 0 11,000
Liabilities of CSMC Trust 0 0 (11,000)
Net unsettled TBAs 0 (14) 0
Derivative collateral offset against derivatives (157,913) 0 0
Dividends and distributions declared, not paid 12,960 12,995 24,313
Principal payments of Residential Whole-Loans, not settled 2,286 1,241 0
Principal payments of Residential Bridge Loans, not settled $ 5,381 $ 0 $ 0